Health care reform expanded health insurance to millions, but current community benefit policies must be used by organizations hoping to address social determinants.
AMA J Ethics. 2019; 21(3):E248-258. doi:
10.1001/amajethics.2019.248.
Where people live and work influences how long and how well they live. Supporting community investments can diminish risk, improve outcomes, and reduce costs.
AMA J Ethics. 2019; 21(3):E262-268. doi:
10.1001/amajethics.2019.262.
Life extension requires careful consideration of resource scarcity, justice, and what, if anything, is intrinsic to the experiences we define as human.
AMA J Ethics. 2019; 21(5):E470-474. doi:
10.1001/amajethics.2019.470.
Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019; 21(10):E844-851. doi:
10.1001/amajethics.2019.844.
Michele C. Gornick, PhD, MA and Brian J. Zikmund-Fisher, PhD, MA
How information is provided can change a choice. Decision science helps reveal affective forecasting errors and can generate choices congruent with patients’ and families’ values.
AMA J Ethics. 2019; 21(10):E906-912. doi:
10.1001/amajethics.2019.906.
Decision making in health care demands that we balance multiple considerations, like quality of life, statistics, and how different options could affect others. Dr Brian Zikmund-Fisher shares his own experience as a patient and explains how decision science can help us navigate ethically complex health decisions.